Shorting is not a good idea with this stock at this pps. It is very volitile and still, i believe, has a good chance in the near future to spike. People are underestimating the positive affect that reaZin had in the recent study. The sub group analysis of over 70 patients is a very valid approach for further studies. At the very least, reaZin can be marketd to AD patients who almost all have a low level of serum zinc. The ONLY issue at the moment is the patent. Adeona has until July 14 to respond to the most recent patent non-final rejection..If they repond and the patent gets approved, this stock will rocket upwards.....not a good idea to short....
There is a reason why shorts can afford to be cocky on this stock
because the pop is now defined and set. in worst case scenario for the shorts, this will shoot up to $1.10s and then come back down to $0.80s
so worst case scenario is known. Now, the good case scenario is that we may fall to below 50 cents in my opinion as I think the MM is trying his level best to push this 6 ft. under. Maybe he is pulling a favor for huge hedge funds who are also short, who knows and the funds may be giving a commission check to the MM to push this down and keep this down
conspiracy theory?? yes, but works in favor of the shorts. I give this co. 4 months of trading, then I say 6 ft under it goes. Cant wait to say RIP AEN